CITRATE PHOSPHATE DEXTROSE Ireland - English - HPRA (Health Products Regulatory Authority)

citrate phosphate dextrose

baxter healthcare limited - glucose monohydrate sodium citrate citric acid monohydrate sodium dihydrogen phosphate dihydrate - unknown - 63 millilitre

CITRATE PHOSPHATE DEXTROSE Ireland - English - HPRA (Health Products Regulatory Authority)

citrate phosphate dextrose

baxter healthcare limited - glucose monohydrate sodium citrate sodium dihydrogen phosphate dihydrate citric acid monohydrate adenine - unknown - 63 millilitre

FENWAL-CPD ADENINE BLOOD PACK UNIT Ireland - English - HPRA (Health Products Regulatory Authority)

fenwal-cpd adenine blood pack unit

baxter healthcare limited - sodium citrate glucose citric acid monohydrate sodium dihydrogen phosphate dihydrate adenine -

FENWAL-CPD ADENINE I BLOOD PACK UNIT Ireland - English - HPRA (Health Products Regulatory Authority)

fenwal-cpd adenine i blood pack unit

baxter healthcare limited - sodium citrate glucose citric acid monohydrate sodium dihydrogen phosphate dihydrate adenine -

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

SODIUM PHOSPHATES- sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous injection, solution United States - English - NLM (National Library of Medicine)

sodium phosphates- sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous injection, solution

hospira, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, monobasic, monohydrate 276 mg in 1 ml - sodium phosphates injection, usp, 3 mm p/ml is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. the concomitant amount of sodium (na+ 4 meq/ml) must be calculated into total electrolyte dose of such prepared solutions. sodium phosphate is contraindicated in diseases where high phosphorus or low calcium levels may be encountered, and in patients with hypernatremia.

GLUCOSE 5% FREEFLEX glucose 12.5 g/250 mL injection bag Australia - English - Department of Health (Therapeutic Goods Administration)

glucose 5% freeflex glucose 12.5 g/250 ml injection bag

fresenius kabi australia pty ltd - glucose, quantity: 12.5 g - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

GLUCOSE 5% FREEFLEX glucose 5g/100mL injection bag Australia - English - Department of Health (Therapeutic Goods Administration)

glucose 5% freeflex glucose 5g/100ml injection bag

fresenius kabi australia pty ltd - glucose, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.